313 related articles for article (PubMed ID: 33166412)
1. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
[TBL] [Abstract][Full Text] [Related]
2. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
5. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
[TBL] [Abstract][Full Text] [Related]
7. Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants.
Sparger KA; Assmann SF; Granger S; Winston A; Christensen RD; Widness JA; Josephson C; Stowell SR; Saxonhouse M; Sola-Visner M
JAMA Pediatr; 2016 Jul; 170(7):687-94. PubMed ID: 27213618
[TBL] [Abstract][Full Text] [Related]
8. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Drews RE
Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusion in hematology, oncology and surgery.
Wandt H; Schäfer-Eckart K; Greinacher A
Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
[TBL] [Abstract][Full Text] [Related]
10. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
Goodnough LT; Kuter DJ; McCullough J; Slichter SJ; DiPersio J; Romo J; Peterson R; Smith KJ; Raife T; Tomita D; Armstrong S
Blood; 2001 Sep; 98(5):1346-51. PubMed ID: 11520781
[TBL] [Abstract][Full Text] [Related]
12. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
13. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats.
Abrams-Ogg AC
Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1401-18. PubMed ID: 14664205
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Platelet Transfusions and Future Areas of Research.
Sola-Visner M; Bercovitz RS
Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytopenia and bleeding in pediatric oncology patients.
Bercovitz RS; Josephson CD
Hematology Am Soc Hematol Educ Program; 2012; 2012():499-505. PubMed ID: 23233625
[TBL] [Abstract][Full Text] [Related]
16. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
17. Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.
Hirooka M; Ochi H; Hiraoka A; Koizumi Y; Tanaka T; Sunago K; Yukimoto A; Imai Y; Watanabe T; Yoshida O; Abe M; Joko K; Michitaka K; Hiasa Y
J Gastroenterol Hepatol; 2020 Feb; 35(2):299-304. PubMed ID: 31318996
[TBL] [Abstract][Full Text] [Related]
18. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins.
Valeri CR; Khuri S; Ragno G
Transfusion; 2007 Oct; 47(4 Suppl):206S-248S. PubMed ID: 17888061
[TBL] [Abstract][Full Text] [Related]
19. Platelets Structure, Function and Modulator Capacity in Replacement Therapy.
Moutinho B; Pinto B; Cardoso R; Botelho MC
Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):180-184. PubMed ID: 29283062
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
